{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:22:04Z","timestamp":1790475724251,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI102264"],"award-info":[{"award-number":["AI102264"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI103782"],"award-info":[{"award-number":["AI103782"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI140499"],"award-info":[{"award-number":["AI140499"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Linda Crnic Institute for Down Syndrome"},{"name":"National Institutes of Health Training","award":["AI052066"],"award-info":[{"award-number":["AI052066"]}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.coi.2018.05.014","type":"journal-article","created":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T13:28:24Z","timestamp":1528378104000},"page":"35-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Crosstalk between type I and II interferons in regulation of myeloid cell responses during bacterial infection"],"prefix":"10.1016","volume":"54","author":[{"given":"William J","family":"Crisler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurel L","family":"Lenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2018.05.014_bib0005","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1098\/rspb.1957.0048","article-title":"Virus interference. I. The interferon","volume":"147","author":"Isaacs","year":"1957","journal-title":"Proc R Soc Lond B Biol Sci"},{"key":"10.1016\/j.coi.2018.05.014_bib0010","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nrd2422","article-title":"Interferons at age 50: past, current and future impact on biomedicine","volume":"6","author":"Borden","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.coi.2018.05.014_bib0015","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/icb.2012.9","article-title":"The interferons and their receptors\u2014distribution and regulation","volume":"90","author":"de Weerd","year":"2012","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.coi.2018.05.014_bib0020","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-II-interferon-mediated signalling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coi.2018.05.014_bib0025","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/ni.3212","article-title":"Guarding the frontiers: the biology of type III interferons","volume":"16","author":"Wack","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2018.05.014_bib0030","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1182\/blood-2010-07-298976","article-title":"IL-29 and IFNalpha differ in their ability to modulate IL-12 production by TLR-activated human macrophages and exhibit differential regulation of the IFNgamma receptor expression","volume":"117","author":"Liu","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.coi.2018.05.014_bib0035","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1084\/jem.20091746","article-title":"Induction of IFN-alphabeta enables Listeria monocytogenes to suppress macrophage activation by IFN-gamma","volume":"207","author":"Rayamajhi","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2018.05.014_bib0040","doi-asserted-by":"crossref","first-page":"8219","DOI":"10.1128\/JVI.78.15.8219-8228.2004","article-title":"Characterization of the murine alpha interferon gene family","volume":"78","author":"van Pesch","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.05.014_bib0045","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","article-title":"Interferon-stimulated genes: a complex web of host defenses","volume":"32","author":"Schneider","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.coi.2018.05.014_bib0050","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ejca.2009.10.013","article-title":"Redefining the role of interferon in the treatment of malignant diseases","volume":"46","author":"Bracarda","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.coi.2018.05.014_bib0055","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.immuni.2012.10.017","article-title":"CDK8 kinase phosphorylates transcription factor STAT1 to selectively regulate the interferon response","volume":"38","author":"Bancerek","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2018.05.014_bib0060","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1101\/gad.479209","article-title":"A phosphorylation-acetylation switch regulates STAT1 signaling","volume":"23","author":"Kramer","year":"2009","journal-title":"Genes Dev"},{"key":"10.1016\/j.coi.2018.05.014_bib0065","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1128\/MCB.05300-11","article-title":"STAT1 signaling is not regulated by a phosphorylation-acetylation switch","volume":"31","author":"Antunes","year":"2011","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.coi.2018.05.014_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2017.06.042","article-title":"Methyltransferase SETD2-mediated methylation of STAT1 is critical for interferon antiviral activity","volume":"170","author":"Chen","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.coi.2018.05.014_bib0075","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41590-017-0003-0","article-title":"Nuclear RNF2 inhibits interferon function by promoting K33-linked STAT1 disassociation from DNA","volume":"19","author":"Liu","year":"2018","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2018.05.014_bib0080","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.immuni.2005.04.008","article-title":"SLIM is a nuclear ubiquitin E3 ligase that negatively regulates STAT signaling","volume":"22","author":"Tanaka","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2018.05.014_bib0085","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/7701","article-title":"A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection","volume":"21","author":"Jouanguy","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.coi.2018.05.014_bib0090","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/S0301-472X(99)00077-6","article-title":"Listeria monocytogenes and recurrent mycobacterial infections in a child with complete interferon-gamma-receptor (IFNgammaR1) deficiency: mutational analysis and evaluation of therapeutic options","volume":"27","author":"Roesler","year":"1999","journal-title":"Exp Hematol"},{"key":"10.1016\/j.coi.2018.05.014_bib0095","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.4049\/jimmunol.1300910","article-title":"Identifying the initiating events of anti-Listeria responses using mice with conditional loss of IFN-gamma receptor subunit 1 (IFNGR1)","volume":"191","author":"Lee","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2018.05.014_bib0100","doi-asserted-by":"crossref","first-page":"877","DOI":"10.4049\/jimmunol.0902346","article-title":"Mice with a selective impairment of IFN-gamma signaling in macrophage lineage cells demonstrate the critical role of IFN-gamma-activated macrophages for the control of protozoan parasitic infections in vivo","volume":"184","author":"Lykens","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2018.05.014_bib0105","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/1074-7613(95)90136-1","article-title":"Tissue-specific targeting of cytokine unresponsiveness in transgenic mice","volume":"3","author":"Dighe","year":"1995","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.coi.2018.05.014_bib0110","first-page":"431","article-title":"Type I interferons in bacterial infections: taming of myeloid cells and possible implications for autoimmunity","author":"Eshleman","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2018.05.014_bib0115","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nri3787","article-title":"Type I interferons in infectious disease","volume":"15","author":"McNab","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coi.2018.05.014_bib0120","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1089\/jir.2005.25.694","article-title":"Hypervirulent M. tuberculosis W\/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway","volume":"25","author":"Manca","year":"2005","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.coi.2018.05.014_bib0125","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1084\/jem.20040712","article-title":"Type I interferon production enhances susceptibility to Listeria monocytogenes infection","volume":"200","author":"O\u2019Connell","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2018.05.014_bib0130","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1172\/JCI35412","article-title":"Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice","volume":"119","author":"Shahangian","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2018.05.014_bib0135","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1126\/science.1235208","article-title":"Blockade of chronic type I interferon signaling to control persistent LCMV infection","volume":"340","author":"Wilson","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.coi.2018.05.014_bib0140","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1126\/science.1235214","article-title":"Persistent LCMV infection is controlled by blockade of type I interferon signaling","volume":"340","author":"Teijaro","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.coi.2018.05.014_bib0145","doi-asserted-by":"crossref","first-page":"e1005378","DOI":"10.1371\/journal.ppat.1005378","article-title":"Functional interplay between type I and II interferons is essential to limit influenza A virus-induced tissue inflammation","volume":"12","author":"Stifter","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coi.2018.05.014_bib0150","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1084\/jem.20040976","article-title":"Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes","volume":"200","author":"Auerbuch","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2018.05.014_bib0155","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.immuni.2011.02.006","article-title":"Type I interferon inhibits interleukin-1 production and inflammasome activation","volume":"34","author":"Guarda","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2018.05.014_bib0160","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.4049\/jimmunol.0904189","article-title":"Caspase-1 independent IL-1beta production is critical for host resistance to Mycobacterium tuberculosis and does not require TLR signaling in vivo","volume":"184","author":"Mayer-Barber","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2018.05.014_sbref0165","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1126\/science.1254790","article-title":"Inflammation. 25-Hydroxycholesterol suppresses interleukin-1-driven inflammation downstream of type I interferon","volume":"345","author":"Reboldi","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.coi.2018.05.014_sbref0170","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature13489","article-title":"Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk","volume":"511","author":"Mayer-Barber","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.coi.2018.05.014_sbref0175","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/ni.3046","article-title":"The methyltransferase Setdb2 mediates virus-induced susceptibility to bacterial superinfection","volume":"16","author":"Schliehe","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2018.05.014_bib0180","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cellimm.2011.11.008","article-title":"Type I interferon signaling regulates the composition of inflammatory infiltrates upon infection with Listeria monocytogenes","volume":"273","author":"Brzoza-Lewis","year":"2012","journal-title":"Cell Immunol"},{"key":"10.1016\/j.coi.2018.05.014_bib0185","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1365-2443.1998.00164.x","article-title":"Type I interferons are essential mediators of apoptotic death in virally infected cells","volume":"3","author":"Tanaka","year":"1998","journal-title":"Genes Cells"},{"key":"10.1016\/j.coi.2018.05.014_bib0190","doi-asserted-by":"crossref","first-page":"15535","DOI":"10.1073\/pnas.0607325103","article-title":"Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responses","volume":"103","author":"Navarini","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2018.05.014_bib0195","doi-asserted-by":"crossref","first-page":"7416","DOI":"10.4049\/jimmunol.173.12.7416","article-title":"IFN regulatory factor 3-dependent induction of type I IFNs by intracellular bacteria is mediated by a TLR- and Nod2-independent mechanism","volume":"173","author":"Stockinger","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2018.05.014_bib0200","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1016\/j.celrep.2018.02.096","article-title":"Detrimental type I interferon signaling dominates protective AIM2 inflammasome responses during Francisella novicida infection","volume":"22","author":"Zhu","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.coi.2018.05.014_bib0205","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1084\/jem.20060045","article-title":"Lymphocytes are detrimental during the early innate immune response against Listeria monocytogenes","volume":"203","author":"Carrero","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2018.05.014_bib0210","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1164\/rccm.201707-1475OC","article-title":"B cells producing type I IFN modulate macrophage polarization in tuberculosis","volume":"197","author":"Benard","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.coi.2018.05.014_bib0215","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.4049\/jimmunol.1502638","article-title":"Chronic type I IFN is sufficient to promote immunosuppression through accumulation of myeloid-derived suppressor cells","volume":"198","author":"Taleb","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2018.05.014_bib0220","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1172\/JCI40817","article-title":"Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte\/macrophage population","volume":"120","author":"Antonelli","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2018.05.014_bib0225","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1084\/jem.120.1.105","article-title":"The immunological basis of acquired cellular resistance","volume":"120","author":"Mackaness","year":"1964","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2018.05.014_bib0230","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1084\/jem.116.3.381","article-title":"Cellular resistance to infection","volume":"116","author":"Mackaness","year":"1962","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2018.05.014_bib0235","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1084\/jem.158.3.670","article-title":"Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity","volume":"158","author":"Nathan","year":"1983","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2018.05.014_bib0240","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1189\/jlb.0603252","article-title":"Interferon-gamma: an overview of signals, mechanisms and functions","volume":"75","author":"Schroder","year":"2004","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.coi.2018.05.014_bib0245","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00335-010-9293-3","article-title":"The immunity-related GTPases in mammals: a fast-evolving cell-autonomous resistance system against intracellular pathogens","volume":"22","author":"Hunn","year":"2011","journal-title":"Mamm Genome"},{"key":"10.1016\/j.coi.2018.05.014_bib0250","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev.immunol.15.1.323","article-title":"Nitric oxide and macrophage function","volume":"15","author":"MacMicking","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.coi.2018.05.014_bib0255","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/CJI.0b013e3181fb045d","article-title":"Interferons induce CXCR3-cognate chemokine production by human metastatic melanoma","volume":"33","author":"Dengel","year":"2010","journal-title":"J Immunother"},{"issue":"9","key":"10.1016\/j.coi.2018.05.014_bib0260","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3389\/fimmu.2018.00141","article-title":"A role for the Krebs cycle intermediate citrate in metabolic reprogramming in innate immunity and inflammation","author":"Williams","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2018.05.014_bib0265","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.imbio.2006.05.007","article-title":"Signal integration between IFNgamma and TLR signalling pathways in macrophages","volume":"211","author":"Schroder","year":"2006","journal-title":"Immunobiology"},{"key":"10.1016\/j.coi.2018.05.014_bib0270","doi-asserted-by":"crossref","first-page":"19438","DOI":"10.1073\/pnas.1007816107","article-title":"IFN-gamma abrogates endotoxin tolerance by facilitating Toll-like receptor-induced chromatin remodeling","volume":"107","author":"Chen","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2018.05.014_bib0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2017.07.017","article-title":"Interferon-gamma represses M2 gene expression in human macrophages by disassembling enhancers bound by the transcription factor MAF","volume":"47","author":"Kang","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2018.05.014_sbref0280","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/ni.3205","article-title":"Interferon-gamma regulates cellular metabolism and mRNA translation to potentiate macrophage activation","volume":"16","author":"Su","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2018.05.014_bib0285","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4049\/jimmunol.139.1.147","article-title":"Internalization and degradation of receptor-bound interferon-gamma by murine macrophages. Demonstration of receptor recycling","volume":"139","author":"Celada","year":"1987","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2018.05.014_bib0290","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1101\/gad.268003","article-title":"DNA binding controls inactivation and nuclear accumulation of the transcription factor Stat1","volume":"17","author":"Meyer","year":"2003","journal-title":"Genes Dev"},{"key":"10.1016\/j.coi.2018.05.014_sbref0295","doi-asserted-by":"crossref","first-page":"13000","DOI":"10.1073\/pnas.1713462114","article-title":"SNX8 mediates IFNgamma-triggered noncanonical signaling pathway and host defense against Listeria monocytogenes","volume":"114","author":"Wei","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2018.05.014_bib0300","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.immuni.2015.05.011","article-title":"Bone-marrow-resident NK cells prime monocytes for regulatory function during infection","volume":"42","author":"Askenase","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2018.05.014_bib0305","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1073\/pnas.94.2.634","article-title":"Interferon-alpha\/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection","volume":"94","author":"Cousens","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2018.05.014_bib0310","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.4049\/jimmunol.135.3.1857","article-title":"Antagonistic effect of interferon-beta on the interferon-gamma-induced expression of Ia antigen in murine macrophages","volume":"135","author":"Ling","year":"1985","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2018.05.014_bib0315","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1084\/jem.167.3.1171","article-title":"Agonist and antagonist effects of interferon alpha and beta on activation of human macrophages. Two classes of interferon gamma receptors and blockade of the high-affinity sites by interferon alpha or beta","volume":"167","author":"Yoshida","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2018.05.014_bib0320","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.4049\/jimmunol.1203510","article-title":"Type I IFNs downregulate myeloid cell IFN-gamma receptor by inducing recruitment of an early growth response 3\/NGFI-A binding protein 1 complex that silences ifngr1 transcription","volume":"191","author":"Kearney","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2018.05.014_bib0325","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1128\/IAI.01743-06","article-title":"Modulation of gamma interferon receptor 1 by Mycobacterium tuberculosis: a potential immune response evasive mechanism","volume":"75","author":"Singhal","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.coi.2018.05.014_bib0330","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/intimm\/dxn119","article-title":"Francisella inhibits STAT1-mediated signaling in macrophages and prevents activation of antigen-specific T cells","volume":"21","author":"Roth","year":"2009","journal-title":"Int Immunol"},{"key":"10.1016\/j.coi.2018.05.014_bib0335","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1126\/science.1233665","article-title":"Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses","volume":"339","author":"Teles","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.coi.2018.05.014_bib0340","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.4049\/jimmunol.1401088","article-title":"Type I IFN induces IL-10 production in an IL-27-independent manner and blocks responsiveness to IFN-gamma for production of IL-12 and bacterial killing in Mycobacterium tuberculosis-infected macrophages","volume":"193","author":"McNab","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2018.05.014_bib0345","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1038\/onc.2009.249","article-title":"The EBV-encoded latent membrane proteins, LMP2A and LMP2B, limit the actions of interferon by targeting interferon receptors for degradation","volume":"28","author":"Shah","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.coi.2018.05.014_sbref0350","doi-asserted-by":"crossref","first-page":"e1006388","DOI":"10.1371\/journal.ppat.1006388","article-title":"Down regulation of macrophage IFNGR1 exacerbates systemic L. monocytogenes infection","volume":"13","author":"Eshleman","year":"2017","journal-title":"PLoS Pathog"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791518300037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791518300037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:43:45Z","timestamp":1760604225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791518300037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":70,"alternative-id":["S0952791518300037"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2018.05.014","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Crosstalk between type I and II interferons in regulation of myeloid cell responses during bacterial infection","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2018.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}